PMH43 - COST-UTILITY ANALYSIS OF CARIPRAZINE COMPARED TO RISPERIDONE AMONG PATIENTS WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN SELECTED CENTRAL AND EASTERN EUROPEAN COUNTRIES
| Autor: | Nemeth, B., Bendes, R., Nagy, B., Deak, I.A., Toth, B., Koczian, K., Horvath, M., Croitoru, C., Tarhajova, M., Psota, M., Kuchar, J., Bucek Psenkova, M., Vokó, Z. |
|---|---|
| Zdroj: | In Value in Health October 2018 21 Supplement 3:S281-S282 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect